International Vaccine Institute (IVI) Email Formats
Non-profit Organizations • 
SNU Research Park, 1 Gwanak-ro, Korea, Republic of • 201-500 Employees
International Vaccine Institute (IVI) Email Formats
International Vaccine Institute (IVI) uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@ivi.int), used 75.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ivi.int | 75.4% |
{first initial}.{last name} | j.doe@ivi.int | 16.4% |
{first initial}{last name} | jdoe@ivi.int | 6.7% |
Key Contacts at International Vaccine Institute (IVI)
Sushant Sahastrabuddhe
Deputy Director General Acting
Birkneh T. Tadesse
Associate Director General
Ravi Ganapathy
Senior Director - Vaccine Process Development
Tharinee Sakhakorn
Program Director, Research Affairs
Anh Wartel
Deputy Director General / Head Of Mission, Head Of Ivi Europe Regional Office Iero, Ivi
In-Kyu Yoon
Senior Scientific Advisor, Director General Unit
Karl Ljungberg
Program Director New Initiatives
Jessica Cowden
Deputy Director General
Richard Henriques
Member Board Of Directors
Alberto Cagigi
Senior Director
Company overview
| Headquarters | SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, KR |
| Phone number | +8228722803 |
| Website | |
| NAICS | 813 |
| SIC | 873 |
| Keywords | Vaccine Delivery, Epidemiology, Capacity-Building, Vaccine Development, Vaccine Discovery |
| Founded | 1997 |
| Employees | 201-500 |
| Socials |
About International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is an independent international organization originally established at the initiative of the United Nations Development Programme in 1997. Its not-for-profit mission is to discover, develop, and deliver safe, effective, and affordable vaccines—empowering vaccine equity, impact, and sustainability globally. IVI’s current portfolio includes vaccines in multiple stages of pre-clinical and clinical development targeting infectious diseases that significantly impact low- and middle-income countries, including cholera, typhoid fever, chikungunya, shigellosis, salmonellosis, schistosomiasis, hepatitis E, HPV- and group A strep-related diseases, and COVID-19. IVI developed the world’s first low-cost oral cholera vaccine and a new-generation typhoid conjugate vaccine, both pre-qualified by the World Health Organization (WHO). IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, an Africa Regional Office in Rwanda, a Country Office in Austria, and a Country and Project Office in Kenya. IVI additionally co-founded the Hong Kong Jockey Club Global Health Institute in Hong Kong and hosts Collaborating Centers in Ghana, Ethiopia, Madagascar, and Burkina Faso. More than 40 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, Austria, Finland, India, and Thailand provide state funding.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
International Vaccine Institute (IVI) has 130 employees across 11 departments.
Departments
Number of employees
Funding Data
International Vaccine Institute (IVI) has never raised funding before.
International Vaccine Institute (IVI) Tech Stack
Discover the technologies and tools that power International Vaccine Institute (IVI)'s digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
JavaScript libraries
JavaScript libraries
Marketing automation
JavaScript libraries
Maps
UI frameworks
JavaScript libraries
WordPress themes
Font scripts
Mexico
China
Canada
United Kingdom
Frequently asked questions
4.8
40,000 users
